V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 10012767 | 10013369 | EJL | 900 | X729 | 2 | 2019-06-01 | TRIAL | 10233659 | 10003563 | 10005702 |
| 10012768 | 10013370 | EE813 | 200 | X731 | 1 | 2018-09-17 | TRIAL | 10234178 | 10008317 | 10005705 |
| 10012769 | 10013371 | EA325 | 10 | null | 2 | 2016-11-25 | TRIAL | 10234178 | 10008317 | 10005706 |
| 10012770 | 10013372 | ETG01 | 262.5 | X721 | 1 | 2016-10-24 | GEMCITABINE | 10235097 | 10003569 | 10005708 |
| 10012771 | 10013373 | EON | 100 | null | 1 | 2019-03-20 | NIVOLUMAB | 10235097 | 10003569 | 10005709 |
| 10012772 | 10013374 | EQ3 | 560 | X729 | 1 | 2015-09-27 | JNJ-42756493 | 10236063 | 10003570 | 10005711 |
| 10012773 | 10013375 | EU8 | 100 | null | 2 | 2014-05-15 | DOCETAXEL | 10237695 | 10003572 | 10005712 |
| 10012774 | 10013376 | EN901 | 260 | X729 | 2 | 2015-01-31 | PAZOPANIB | 10238927 | 10003574 | 10005715 |
| 10012775 | 10013377 | EU8 | 200 | X729 | 1 | 2017-04-11 | IBRUTINIB | 10241016 | 10006938 | 10005717 |
| 10012776 | 10013378 | EAF01 | 480 | X729 | 1 | 2017-11-27 | ENZALUTAMIDE | 10241519 | 10003577 | 10005718 |
| 10012777 | 10013379 | EGR00 | 4 | X722 | 2 | 2019-02-14 | TRIAL | 10242036 | 10003578 | 10005719 |
| 10012778 | 10013380 | ECL01 | 100 | null | 2 | 2017-02-01 | LENALIDOMIDE | 10244038 | 10003582 | 10005722 |
| 10012779 | 10013381 | EGR00 | 80 | null | 1 | 2019-01-08 | SILTUXIMAB | 10244291 | 10003583 | 10005723 |
| 10012780 | 10013382 | EKX01 | 200 | X731 | 1 | 2018-07-23 | NIVOLUMAB | 10244291 | 10003583 | 10005724 |
| 10012781 | 10013383 | EE101 | 110 | X731 | 2 | 2018-03-11 | ATEZOLIZUMAB | 10245292 | 10003586 | 10005726 |
| 10012782 | 10013384 | EAF01 | 1200 | X729 | 1 | 2016-02-28 | SILTUXIMAB | 10245829 | 10003589 | 10005729 |
| 10012783 | 10013386 | EGR00 | 560 | null | 2 | 2015-12-08 | PACLITAXEL | 10246452 | 10003594 | 10005733 |
| 10012784 | 10013387 | EJC | 40 | null | 1 | 2016-01-25 | NOT MATCHED | 10246452 | 10003594 | 10005734 |
| 10012785 | 10013388 | EK1PP | 1000 | null | 1 | 2017-02-15 | NIVOLUMAB | 10247058 | 10006945 | 10005735 |
| 10012786 | 10013389 | EA325 | 100 | null | 1 | 2018-06-22 | NIVOLUMAB | 10247661 | 10003597 | 10005737 |
| 10012787 | 10013390 | EA325 | 160 | null | 2 | 2018-09-30 | CAPECITABINE | 10250094 | 10003600 | 10005741 |
| 10012788 | 10013391 | EN710 | 6 | X729 | 1 | 2018-11-30 | NIVOLUMAB | 10250247 | 10003606 | 10005743 |
| 10012789 | 10013392 | EN710 | 240 | null | null | 2017-01-14 | PAZOPANIB | 10251464 | 10003607 | 10005744 |
| 10012790 | 10013393 | EGR00 | 800 | X723 | 2 | 2018-08-23 | ENZALUTAMIDE | 10251464 | 10003607 | 10005747 |
| 10012791 | 10013394 | EGR00 | 200 | null | 1 | 2018-07-18 | NOT MATCHED | 10254770 | 10003610 | 10005750 |
| 10012792 | 10013395 | EU8 | 10 | X721 | 2 | 2017-08-28 | RUXOLITINIB | 10257041 | 10006954 | 10005752 |
| 10012793 | 10013396 | EGR00 | 110 | null | 2 | 2016-05-25 | TRIAL | 10257041 | 10006954 | 10005754 |
| 10012794 | 10013397 | EN710 | 68 | X723 | 1 | 2016-12-12 | MLN1117 | 10259113 | 10003615 | 10005756 |
| 10012795 | 10013398 | EN710 | 16 | X723 | 2 | 2014-05-07 | PEMBROLIZUMAB | 10259113 | 10003615 | 10005757 |
| 10012796 | 10013399 | EU8 | 50 | X721 | 2 | 2017-12-13 | PEMBROLIZUMAB | 10259113 | 10003615 | 10005758 |
| 10012797 | 10013400 | EGR00 | 280 | null | 1 | 2018-11-09 | NIVOLUMAB | 10261071 | 10003617 | 10005759 |
| 10012798 | 10013401 | EGR00 | null | X729 | 1 | 2017-05-26 | ATEZOLIZUMAB | 10261233 | 10003619 | 10005761 |
| 10012799 | 10013402 | EN710 | 160 | X731 | 1 | 2018-06-13 | PEMBROLIZUMAB | 10262332 | 10003620 | 10005762 |
| 10012800 | 10013403 | EN710 | 162.5 | X721 | 1 | 2015-05-07 | TRIAL | 10265007 | 10003623 | 10005765 |
| 10012801 | 10013404 | ECL02 | 20 | X731 | 1 | 2017-03-26 | NIVOLUMAB | 10265848 | 10003624 | 10005766 |
| 10012802 | 10013405 | ERA20 | 260 | null | 2 | 2017-03-06 | JNJ-42756493 | 10266032 | 10006959 | 10005767 |
| 10012803 | 10013406 | EGQ01 | 10 | X731 | 2 | 2018-04-27 | STEROID | 10267419 | 10003626 | 10005770 |
| 10012804 | 10013407 | EKS | 2 | null | 5 | 2015-11-24 | NOT CHEMO | 10273322 | 10003631 | 10005774 |
| 10012805 | 10013408 | EJR | 100 | null | 1 | 2017-09-29 | TRIAL | 10273322 | 10003631 | 10005775 |
| 10012806 | 10013409 | EJR | 1200 | null | 2 | 2018-08-01 | SUNITINIB | 10275064 | 10003633 | 10005777 |
| 10012807 | 10013410 | ETA90 | 1680 | X729 | 2 | 2017-06-05 | PEMBROLIZUMAB | 10275183 | 10003634 | 10005778 |
| 10012808 | 10013411 | EK1PP | 110 | null | 2 | 2016-11-23 | STEROID | 10275539 | 10008330 | 10005779 |
| 10012809 | 10013412 | EII | 160 | X729 | 1 | 2018-10-17 | CYTARABINE | 10275965 | 10006966 | 10005782 |
| 10012810 | 10013413 | ECL02 | 950 | X729 | 2 | 2017-10-19 | NOT MATCHED | 10276088 | 10003636 | 10005783 |
| 10012811 | 10013414 | ECL02 | 400 | null | 2 | 2015-06-14 | OSIMERTINIB | 10276298 | 10003637 | 10005784 |
| 10012812 | 10013415 | EII | 1118 | X722 | 2 | 2019-05-26 | AZACITIDINE | 10276501 | 10003638 | 10005785 |
| 10012813 | 10013416 | ECL02 | 20 | null | 2 | 2015-08-01 | OXALIPLATIN | 10276501 | 10003639 | 10005786 |
| 10012814 | 10013417 | ECL02 | 200 | X723 | null | 2015-05-24 | DARATUMUMAB | 10276519 | 10003640 | 10005787 |
| 10012815 | 10013418 | EII | 200 | null | 1 | 2018-02-02 | ATEZOLIZUMAB | 10276519 | 10003640 | 10005788 |
| 10012816 | 10013419 | EII | 2128 | X723 | 1 | 2014-04-03 | CARBOPLATIN | 10276568 | 10003641 | 10005789 |